Expression of interferon-inducible Mx-proteins in patients with IgA nephropathy or Henoch-Schonlein purpura

Citation
J. Floege et al., Expression of interferon-inducible Mx-proteins in patients with IgA nephropathy or Henoch-Schonlein purpura, AM J KIDNEY, 33(3), 1999, pp. 434-440
Citations number
41
Categorie Soggetti
Urology & Nephrology
Journal title
AMERICAN JOURNAL OF KIDNEY DISEASES
ISSN journal
02726386 → ACNP
Volume
33
Issue
3
Year of publication
1999
Pages
434 - 440
Database
ISI
SICI code
0272-6386(199903)33:3<434:EOIMIP>2.0.ZU;2-Y
Abstract
Both viral infections and dysregulated cytokine synthesis have been implica ted in the pathogenesis of immunoglobulin A nephropathy (IgAN) and Henoch-S chonlein purpura (HSP), Mr proteins are specifically induced by type I inte rferons (IFN-alpha, -beta, -omega) and are very sensitive in detecting, for example, virus-induced, in vivo production of IFN-alpha/-beta, because the biological half-life of Mx (similar to 3 days) markedly exceeds that of IF N-alpha/-beta (20 to 90 minutes), Mr concentrations in leukocytes were meas ured by enzyme-linked immunosorbent assay (ELISA) in 79 blood samples of 35 patients with IgAN and five with HSP. No patient showed symptoms of infect ions at the time of the examination. Compared with normal leukocyte Mr conc entrations (<2 mU/1,000 leukocytes), only 3 of 79 samples of IgAN/HSP patie nts showed mildly elevated Mr concentrations (range, 2.2 to 3 mU/1,000 leuk ocytes), By contrast, patients with increased endogenous IFN production (lu pus erythematosus) or patients treated with IFN-alpha(2) showed leukocyte M r concentrations of up to 35 mU/1,000 leukocytes, In patients with IgAN and HSP, leukocyte Mr concentrations were not correlated with various clinical parameters. Immunohistochemically, no renal Mr expression could be detecte d in eight renal biopsy specimens of patients with various stages of IgAN, whereas control specimens (skin of patients treated with IFN-(alpha 2)) sho wed abundant cellular Mx expression, Furthermore, human mesangial cells in vitro showed marked Mx production after exposure to IFN-alpha or IFN-beta. We conclude that, in patients with IgAN/HSP, no evidence of an activation o r dysregulation of the type I interferon system can be detected, (C) 1999 b y the National Kidney Foundation, Inc.